The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
Kindblom, L. G., Remotti, H. E., Aldenborg, F., & Meis‐Kindblom, J. M. (1998) · Europe PMC (PubMed Central) · Cited by 1,667
Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, Å., Westermark, B., Heldin, C.-H., Huang, J. S., & Deuel, T. F. (1983) · Nature · doi:10.1038/304035a0 · Cited by 1,616
Doolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., & Antoniades, H. N. (1983) · Science · doi:10.1126/science.6304883 · Cited by 1,536
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“The well-characterized RIPTag2 transgenic mice tumor model, in which large T antigen is expressed under the control of the insulin promoter, allows the design of experimental therapy trials where efficacy during different phases of tumor development are tested [80].”
BackgroundAbnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C. (2001) · Genes & Development · doi:10.1101/gad.903001 · Cited by 708
Hermanson, M., Funa, N. S., Hartman, M., Claesson, L., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 705
Hirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., & Kitamura, Y. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01046-1 · Cited by 666
Heinrich, M. C., Blanke, C. D., Druker, B. J., & Corless, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1692 · Cited by 634
Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
Erber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0271fje · Cited by 610
Management of malignant gastrointestinal stromal tumours
Joensuu, H., Fletcher, C., Dimitrijevic, S., Silberman, S., Roberts, P., & Demetri, G. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00899-9 · Cited by 567
Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 562
Simon, M.-P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.-M., Terrier-Lacombe, M.-J., Mandahl, N., Craver, R., Blin, N., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-95 · Cited by 535
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers
Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., et al. (2003) · Science · doi:10.1126/science.1082596 · Cited by 484
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Self-citationInhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 433
Self-citationPardanani, A., Ketterling, R. P., Brockman, S. R., Flynn, H. C., Paternoster, S. F., Shearer, B. M., Reeder, T. L., Li, C.-Y., Cross, N. C. P., Cools, J., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1627 · Cited by 393
(1992) · PubMed · Cited by 383
Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H.-J. S., Cavenee, W. K., & Cheng, S.-Y. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63905-3 · Cited by 367
Rubin, B. P., Schuetze, S. M., Eary, J. F., Norwood, T. H., Mirza, S. K., Conrad, E. U., & Bruckner, J. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.027 · Cited by 364
Kilic, T., Alberta, J. A., Zdunek, P. R., Acar, M., Iannarelli, P., O'Reilly, T., Buchdunger, E., Black, P. M., & Stiles, C. D. (2000) · PubMed · Cited by 310
Sirvent, N., Maire, G., & Pedeutour, F. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10202 · Cited by 310
Sjöblom, T., Shimizu, A., O'Brien, K. P., Pietras, K., Cin, P. D., Buchdunger, E., Dumanski, J. P., Östman, A., & Heldin, C. (2001) · PubMed · Cited by 298
Self-citationGotlib, J., Cools, J., Malone, J. M., Schrier, S. L., Gilliland, D. G., & Coutré, S. E. (2004) · Blood · doi:10.1182/blood-2003-06-1824 · Cited by 290
Shimizu, A., O'Brien, K. P., Sjöblom, T., et al. (1999) · PubMed · Cited by 289
Hermansson, M., Nistér, M., Betsholtz, C., Heldin, C., Westermark, B., & Funa, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7748 · Cited by 286
Platelet-Derived Growth Factor is Angiogenic In Vivo
Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., & Heldin, C.-H. (1992) · Growth Factors · doi:10.3109/08977199209046408 · Cited by 283
Uhrbom, L., Hesselager, G., Nistér, M., & Westermark, B. (1998) · PubMed · Cited by 283
Uehara, H., Kim, S. J., Karashima, T., Shepherd, D. L., Fan, D., Tsan, R., Killion, J. J., Logothetis, C., Mathew, P., & Fidler, I. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.458 · Cited by 280
Carroll, M., Tomasson, M. H., Barker, G. F., Golub, T. R., & Gilliland, D. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14845 · Cited by 268
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Maki, R. G., Awan, R. A., Dixon, R. H., Jhanwar, S., & Antonescu, C. R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10535 · Cited by 250
Klion, A. D., Robyn, J., Akin, C., Noel, P., Brown, M., Law, M., Metcalfe, D. D., Dunbar, C., & Nutman, T. B. (2004) · Blood · doi:10.1182/blood-2003-08-2798 · Cited by 240
Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M., & Westermark, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.393 · Cited by 238
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
Skobe, M., & Fusenig, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1050 · Cited by 233
Cao, R., Bråkenhielm, E., Li, X., Pietras, K., Widenfalk, J., Östman, A., Eriksson, U., & Cao, Y. (2002) · The FASEB Journal · doi:10.1096/fj.02-0319com · Cited by 229
Self-citationImatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
Pardanani, A., Reeder, T., Porrata, L. F., Li, C.-Y., Tazelaar, H. D., Baxter, E. J., Witzig, T. E., Cross, N. C. P., & Tefferi, A. (2003) · Blood · doi:10.1182/blood-2002-10-3103 · Cited by 227
Human breast carcinoma desmoplasia is PDGF initiated
Shao, Z.-M., Nguyen, M., & Barsky, S. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203785 · Cited by 221
Plate, K. H., Breier, G., Farrell, C. L., & Risau, W. (1992) · PubMed · Cited by 219
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
Shah, N. P., & Sawyers, C. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206942 · Cited by 216
Cools, J., Stover, E. H., Boulton, C. L., Gotlib, J., Legare, R. D., Amaral, S. M., Curley, D. P., Duclos, N., Rowan, R., Kutok, J. L., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00108-9 · Cited by 216
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
Furuhashi, M., Sjöblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Bergsten-Folestad, E., Eriksson, U., Heuchel, R., Betsholtz, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1489 · Cited by 203
Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome
Griffin, J. H., Leung, J., Bruner, R. J., Caligiuri, M. A., & Briesewitz, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932698100 · Cited by 202
Josephs, S. F., Guo, C., Ratner, L., & Wong-Staal, F. (1984) · Science · doi:10.1126/science.6318322 · Cited by 194
A role of PDGFRα in basal cell carcinoma proliferation
Xie, J., Aszterbaum, M., Zhang, X., Bonifas, J. M., Zachary, C., Epstein, E., & McCormick, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151173398 · Cited by 192
Fjällskog, M.-L. H., Lejonklou, M. H., Öberg, K. E., Eriksson, B. K., & Janson, E. T. (2003) · PubMed · Cited by 189
Heuchel, R., Berg, A., Tallquist, M., Åhlén, K., Reed, R. K., Rubin, K., Claesson-Welsh, L., Heldin, C.-H., & Soriano, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11410 · Cited by 188
Ross, T. S., Bernard, O. A., Berger, R., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v91.12.4419 · Cited by 186
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
Lee, S. B., Kolquist, K. A., Nichols, K., Englert, C., Maheswaran, S., Ladanyi, M., Gerald, W. L., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng1197-309 · Cited by 180
Transformation of NIH 3T3 cells by a human c-sis cDNA clone
Clarke, M. F., Westin, E., Schmidt, D., Josephs, S. F., Ratner, L., Wong-Staal, F., Gallo, R. C., & Reitz, M. S. (1984) · Nature · doi:10.1038/308464a0 · Cited by 178
Analysis of Mural Cell Recruitment to Tumor Vessels
Abramsson, A., Berlin, O., Papayan, H., Paulin, D., Shani, M., & Betsholtz, C. (2002) · Circulation · doi:10.1161/hc0102.101437 · Cited by 178
Hwang, R. F., Yokoi, K., Bucana, C. D., Tsan, R. Z., Killion, J. J., Evans, D. B., & Fidler, I. J. (2003) · PubMed · Cited by 176
Comparison of Biological Properties and Transforming Potential of Human PDGF-A and PDGF-B Chains
Beckmann, M. P., Betsholtz, C., Heldin, C.-H., Westermark, B., Di Marco, E., Di Fiore, P. P., Robbins, K. C., & Aaronson, S. A. (1988) · Science · doi:10.1126/science.2842868 · Cited by 174
PDGF-D is a potent transforming and angiogenic growth factor
Li, H., Fredriksson, L., Li, X., & Eriksson, U. (2003) · Oncogene · doi:10.1038/sj.onc.1206223 · Cited by 170
Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation
Gazit, A., Igarashi, H., Chiu, I.-M., Srinivasan, A., Yaniv, A., Tronick, S. R., Robbins, K. C., & Aaronson, S. A. (1984) · Cell · doi:10.1016/0092-8674(84)90194-6 · Cited by 163
Beppu, K., Jaboine, J., Merchant, M., Mackall, C. L., & Thiele, C. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh004 · Cited by 162
Sundberg, C., Ljungström, M., Lindmark, G. E., Gerdin, B., & Rubin, K. (1993) · PubMed · Cited by 143
Magnússon, M. K., Meade, K. E., Brown, K. E., Arthur, D. C., Krueger, L. A., Barrett, A. J., & Dunbar, C. E. (2001) · Blood · doi:10.1182/blood.v98.8.2518 · Cited by 141
STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.
Pietras, K., Stumm, M., Hubert, M., Buchdunger, E., Rubin, K., Heldin, C., McSheehy, P. M. J., Wartmann, M., & Östman, A. (2003) · PubMed · Cited by 141
Self-citationMatei, D. E., Chang, D. D., & Jeng, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0754-03 · Cited by 136
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
Zwerner, J. P., & May, W. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204133 · Cited by 128
Tyrosine kinase fusion genes in chronic myeloproliferative diseases
Cross, N. C. P., & Reiter, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402556 · Cited by 126
Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T., & Saito, H. (1997) · Blood · doi:10.1182/blood.v90.11.4271 · Cited by 125
Ebert, M., Yokoyama, M., Friess, H., Kobrin, M. S., Büchler, M. W., & Korc, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620507 · Cited by 125
A human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 124
Greco, A., Fusetti, L., Villa, R., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202051 · Cited by 116
Apte, S. M., Fan, D., Killion, J. J., & Fidler, I. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1151-3 · Cited by 114
Tomasson, M. H., Sternberg, D., Williams, I. R., Carroll, M. P., Cain, D., Aster, J. C., Ilaria, R. L., Etten, R. A. V., & Gilliland, D. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8902 · Cited by 111
Simon, M., Navarro, M., Roux, D., & Pouysségur, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204426 · Cited by 109
Tomasson, M. H., Williams, I. R., Hasserjian, R. P., Udomsakdi, C., McGrath, S. M., Schwaller, J., Druker, B. J., & Gilliland, D. G. (1999) · Blood · doi:10.1182/blood.v93.5.1707 · Cited by 108
Expression in lung carcinomas of platelet-derived growth factor and its receptors.
Kawai, T., Hiroi, S., & Torikata, C. (1997) · PubMed · Cited by 97
A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer Progression
Ustach, C. V., Taube, M. E., Hurst, N. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3047 · Cited by 95
Smits, A. M., Funa, N. S., Vassbotn, F. S., Beausang-Linder, M., af Ekenstam, F., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 91
Epithelial-Stromal Interactions in Basal Cell Cancer: The PDGF System
Pontén, F., Ren, Z.-P., Nistér, M., Westermark, B., & Pontén, J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371787 · Cited by 90
Cools, J., Quentmeier, H., Huntly, B. J. P., Marynen, P., Griffin, J. D., Drexler, H. G., & Gilliland, D. G. (2003) · Blood · doi:10.1182/blood-2003-07-2479 · Cited by 88
Lindmark, G. E., Sundberg, C., Glimelius, B. L. G., et al. (1993) · PubMed · Cited by 82
Bhardwaj, B., Klassen, J., Cossette, N., et al. (1996) · PubMed · Cited by 81
Funa, N. S., Papanicolaou, V., Juhlin, C., Rastad, J., Åkerström, G., Heldin, C. H., & Öberg, K. (1990) · PubMed · Cited by 78
Kumabe, T., SOHMA, Y., Kayama, T., Yoshimoto, T., & Yamamoto, T. (1992) · PubMed · Cited by 75
(2003) · PubMed · Cited by 67
Wang, J., Coltrera, M. D., & Gown, A. M. (1994) · PubMed · Cited by 64
Trempat, P., Villalva, C., Laurent, G., Armstrong, F., Delsol, G., Dastugue, N., & Brousset, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206543 · Cited by 63
Tamborini, E., Bonadiman, L., Greco, A., Gronchi, A., Riva, C., Bertulli, R., Casali, P. G., Pierotti, M. A., & Pilotti, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0059 · Cited by 63
Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
Zwerner, J. P., & May, W. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205486 · Cited by 56
Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein
Sjöblom, T., Boureux, A., Rönnstrand, L., Heldin, C., Ghysdael, J., & Östman, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203190 · Cited by 40
Self-citation
Cited by
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Cancer as an overhealing wound: an old hypothesis revisited
Schäfer, M., & Werner, S. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2455 · Cited by 956
Glioblastoma multiforme: Pathogenesis and treatment
Alifieris, C., & Trafalis, D. T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.005 · Cited by 820
Bremnes, R. M., Dønnem, T., Al-Saad, S., Al-Shibli, K., Andersen, S., Sirera, R., Camps, C., Marinez, I., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f8a1bd · Cited by 691
Metadata
- Authors
- Östman, A.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 15
- Issue
- 4
- Pages
- 275-286
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2072483737
- Cited by
- 326
- References
- 98
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.